SaaS founders should understand whether their product creates EU-facing AI exposure, whether they act as provider or deployer, and which documentation, oversight or risk controls are needed before scaling.
Operational information, not legal advice.
Company exposure map
Business context
EU customers, users or output
AI product or workflow use
Exposure path
Strategic answer
A SaaS company can create EU AI Act exposure through product features, customer workflows, AI outputs or EU market access. Founders should understand role, risk and documentation needs before growth turns a small feature into a governance liability.
Start with the EU AI Act Diagnostic, turn findings into an implementation plan, and see how the diagnostic works as a reference app on M13.
Exposure focus
First action
This page provides operational information for AI governance readiness. It is not legal advice.
Related guides
Run a diagnostic-first EU AI Act assessment for role, risk, documentation and implementation exposure.
Clarify the difference between provider and deployer roles under EU AI Act readiness work.
A practical guide to assessing EU AI Act risk before committing budget to implementation.
Build a practical implementation path after scope, role and risk have been diagnosed.
Official sources
External references are included for source orientation. This page remains operational information and is not legal advice.
